Published in Inhal Toxicol on June 01, 2004
Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect (2005) 17.71
Adverse cardiovascular effects of air pollution. Nat Clin Pract Cardiovasc Med (2008) 3.00
Exposure to concentrated ambient particles does not affect vascular function in patients with coronary heart disease. Environ Health Perspect (2008) 1.45
The adverse effects of air pollution on the nervous system. J Toxicol (2012) 1.28
Manufactured and airborne nanoparticle cardiopulmonary interactions: a review of mechanisms and the possible contribution of mast cells. Inhal Toxicol (2012) 1.02
Lack of acute phase response in the livers of mice exposed to diesel exhaust particles or carbon black by inhalation. Part Fibre Toxicol (2009) 0.95
Cardiac oxidative stress and dysfunction by fine concentrated ambient particles (CAPs) are mediated by angiotensin-II. Inhal Toxicol (2010) 0.89
Particulate matter (PM) research centers (1999-2005) and the role of interdisciplinary center-based research. Environ Health Perspect (2008) 0.88
Xenobiotic particle exposure and microvascular endpoints: a call to arms. Microcirculation (2012) 0.88
Interaction effects of ultrafine carbon black with iron and nickel on heart rate variability in spontaneously hypertensive rats. Environ Health Perspect (2007) 0.83
Pulmonary effects of inhaled limonene ozone reaction products in elderly rats. Toxicol Appl Pharmacol (2007) 0.79
Multi-walled carbon nanotubes change morpho-functional and GABA characteristics of mouse cortical astrocytes. J Nanobiotechnology (2015) 0.76
From the Cover: Disease-Induced Disparities in Formation of the Nanoparticle-Biocorona and the Toxicological Consequences. Toxicol Sci (2016) 0.76
Safe handling of nanotechnology. Nature (2006) 7.25
Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats. J Toxicol Environ Health A (2002) 3.49
Air pollution and markers of inflammation and coagulation in patients with coronary heart disease. Am J Respir Crit Care Med (2005) 3.36
Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ Health Perspect (2006) 3.16
Ultrafine particle deposition in humans during rest and exercise. Inhal Toxicol (2003) 2.06
Size dependence of the translocation of inhaled iridium and carbon nanoparticle aggregates from the lung of rats to the blood and secondary target organs. Inhal Toxicol (2009) 1.78
Ultrafine particles in the urban air: to the respiratory tract--and beyond? Environ Health Perspect (2002) 1.76
The influence of protein adsorption on nanoparticle association with cultured endothelial cells. Biomaterials (2008) 1.68
Efficient elimination of inhaled nanoparticles from the alveolar region: evidence for interstitial uptake and subsequent reentrainment onto airways epithelium. Environ Health Perspect (2007) 1.65
Meeting report: hazard assessment for nanoparticles--report from an interdisciplinary workshop. Environ Health Perspect (2007) 1.64
Does Nanoparticle Activity Depend upon Size and Crystal Phase? Nanotoxicology (2008) 1.62
Concept of assessing nanoparticle hazards considering nanoparticle dosemetric and chemical/biological response metrics. J Toxicol Environ Health A (2010) 1.61
Interlaboratory evaluation of rodent pulmonary responses to engineered nanomaterials: the NIEHS Nano GO Consortium. Environ Health Perspect (2013) 1.52
The U.S. Environmental Protection Agency Particulate Matter Health Effects Research Centers Program: a midcourse report of status, progress, and plans. Environ Health Perspect (2003) 1.51
Correlating physico-chemical with toxicological properties of nanoparticles: the present and the future. ACS Nano (2010) 1.49
Pulmonary function, diffusing capacity, and inflammation in healthy and asthmatic subjects exposed to ultrafine particles. Inhal Toxicol (2004) 1.45
Inhalation of ultrafine particles alters blood leukocyte expression of adhesion molecules in humans. Environ Health Perspect (2006) 1.44
Ultrafine particles and platelet activation in patients with coronary heart disease--results from a prospective panel study. Part Fibre Toxicol (2007) 1.43
Neonatal oxygen adversely affects lung function in adult mice without altering surfactant composition or activity. Am J Physiol Lung Cell Mol Physiol (2009) 1.41
Ultrafine particle deposition in subjects with asthma. Environ Health Perspect (2004) 1.40
Effects of subchronically inhaled carbon black in three species. I. Retention kinetics, lung inflammation, and histopathology. Toxicol Sci (2005) 1.30
The rat ear vein model for investigating in vivo thrombogenicity of ultrafine particles (UFP). Toxicol Sci (2005) 1.29
Effects of exposure to ultrafine carbon particles in healthy subjects and subjects with asthma. Res Rep Health Eff Inst (2004) 1.25
Equivalent titanium dioxide nanoparticle deposition by intratracheal instillation and whole body inhalation: the effect of dose rate on acute respiratory tract inflammation. Part Fibre Toxicol (2014) 1.24
Pulmonary response after exposure to inhaled nickel hydroxide nanoparticles: short and long-term studies in mice. Nanotoxicology (2010) 1.20
Translocation and effects of ultrafine particles outside of the lung. Clin Occup Environ Med (2006) 1.20
Changes in deceleration capacity of heart rate and heart rate variability induced by ambient air pollution in individuals with coronary artery disease. Part Fibre Toxicol (2010) 1.16
Concepts of nanoparticle dose metric and response metric. Environ Health Perspect (2007) 1.12
Continued controversy on chrysotile biopersistence. Int J Occup Environ Health (2011) 1.12
Lead exposure inhibits fracture healing and is associated with increased chondrogenesis, delay in cartilage mineralization, and a decrease in osteoprogenitor frequency. Environ Health Perspect (2005) 1.11
Low levels of copper disrupt brain amyloid-β homeostasis by altering its production and clearance. Proc Natl Acad Sci U S A (2013) 1.11
The origin, fate, and health effects of combustion by-products: a research framework. Environ Health Perspect (2002) 1.10
Nanotoxicology: in vitro-in vivo dosimetry. Environ Health Perspect (2012) 1.09
Recirculating air filtration significantly reduces exposure to airborne nanoparticles. Environ Health Perspect (2008) 1.03
Activation of pulmonary dendritic cells and Th2-type inflammatory responses on instillation of engineered, environmental diesel emission source or ambient air pollutant particles in vivo. J Innate Immun (2010) 1.03
A comparative dose-related response of several key pro- and antiinflammatory mediators in the lungs of rats, mice, and hamsters after subchronic inhalation of carbon black. J Occup Environ Med (2006) 1.03
Validation of an LDH assay for assessing nanoparticle toxicity. Toxicology (2011) 1.03
ECG parameters and exposure to carbon ultrafine particles in young healthy subjects. Inhal Toxicol (2009) 1.02
CD8+ T cell immunity to 2009 pandemic and seasonal H1N1 influenza viruses. Vaccine (2011) 1.02
Induction of chemokines by low-dose intratracheal silica is reduced in TNFR I (p55) null mice. Toxicol Sci (2003) 1.01
A nanoparticle dispersion method for in vitro and in vivo nanotoxicity study. Nanotoxicology (2010) 1.00
On-road exposure to highway aerosols. 2. Exposures of aged, compromised rats. Inhal Toxicol (2004) 0.98
Early postnatal exposure to ultrafine particulate matter air pollution: persistent ventriculomegaly, neurochemical disruption, and glial activation preferentially in male mice. Environ Health Perspect (2014) 0.97
Comparing inhaled ultrafine versus fine zinc oxide particles in healthy adults: a human inhalation study. Am J Respir Crit Care Med (2005) 0.97
Organic and inorganic mercury in neonatal rat brain after prenatal exposure to methylmercury and mercury vapor. Environ Health Perspect (2010) 0.97
Methylmercury contamination of laboratory animal diets. Environ Health Perspect (2005) 0.95
The adaptive significance of unproductive alternative splicing in primates. RNA (2010) 0.93
Nanoparticle (NP) uptake by type I alveolar epithelial cells and their oxidant stress response. Nanotoxicology (2009) 0.92
Developmental exposure to concentrated ambient particles and preference for immediate reward in mice. Environ Health Perspect (2012) 0.92
Pneumocystis carinii infection sensitizes lung to radiation-induced injury after syngeneic marrow transplantation: role of CD4+ T cells. Am J Physiol Lung Cell Mol Physiol (2006) 0.92
Application of an informatics-based decision-making framework and process to the assessment of radiation safety in nanotechnology. Health Phys (2015) 0.91
Effects of on-road highway aerosol exposures on autonomic responses in aged, spontaneously hypertensive rats. Inhal Toxicol (2007) 0.90
Short-term effects of air pollution: a panel study of blood markers in patients with chronic pulmonary disease. Part Fibre Toxicol (2009) 0.90
Extraction and quantification of carbon nanotubes in biological matrices with application to rat lung tissue. ACS Nano (2013) 0.89
Galactosylated LDL nanoparticles: a novel targeting delivery system to deliver antigen to macrophages and enhance antigen specific T cell responses. Mol Pharm (2009) 0.89
Particulate matter (PM) research centers (1999-2005) and the role of interdisciplinary center-based research. Environ Health Perspect (2008) 0.88
Time course of lung retention and toxicity of inhaled particles: short-term exposure to nano-Ceria. Arch Toxicol (2014) 0.88
Assessing the relevance of in vitro studies in nanotoxicology by examining correlations between in vitro and in vivo data. Toxicology (2012) 0.86
Endotoxin potentiates ozone-induced pulmonary chemokine and inflammatory responses. Exp Lung Res (2002) 0.86
Impact of ambient air pollution on the differential white blood cell count in patients with chronic pulmonary disease. Inhal Toxicol (2010) 0.86
Nitrogen dioxide exposure: effects on airway and blood cells. Am J Physiol Lung Cell Mol Physiol (2002) 0.86
Formation of PAH-DNA adducts after in vivo and vitro exposure of rats and lung cells to different commercial carbon blacks. Toxicol Appl Pharmacol (2005) 0.85
Incorporation of particle size differences between animal studies and human workplace aerosols for deriving exposure limit values. Regul Toxicol Pharmacol (2010) 0.85
Iron deficiency disrupts axon maturation of the developing auditory nerve. J Neurosci (2012) 0.85
Postnatal lung development: immediate-early gene responses post ozone and LPS exposure. Inhal Toxicol (2006) 0.85
Manganese transport via the transferrin mechanism. Neurotoxicology (2012) 0.83
Quantification of quantum dot murine skin penetration with UVR barrier impairment. Nanotoxicology (2013) 0.83
The E2F-1 transcription factor promotes caspase-8 and bid expression, and enhances Fas signaling in T cells. J Immunol (2004) 0.80
Derivation of PM10 size-selected human equivalent concentrations of inhaled nickel based on cancer and non-cancer effects on the respiratory tract. Inhal Toxicol (2014) 0.77
In vitro dosing of cells with poorly soluble particles. Toxicol Sci (2006) 0.76
Quantitative risk analyses for RCF: survey and synthesis. Regul Toxicol Pharmacol (2003) 0.76
Reducing exposure to airborne particles: a novel strategy to improve cardiovascular health. Am J Respir Crit Care Med (2008) 0.75
Report: Combustion Byproducts and Their Health Effects: Summary of the 10th International Congress. Environ Eng Sci (2008) 0.75
Percutaneous absorption studies of octamethylcyclotetrasiloxane using the human skin/nude mouse model. Skin Pharmacol Appl Skin Physiol (2002) 0.75
[Toxicity of nano silica particles on rat type I-like alveolar epithelial cells]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi (2009) 0.75